טוען...

Zoledronic acid is effective in the management of migratory osteoporosis unresponsive to conservative treatment and risedronate: A case report

We describe a case of a 55-year-old woman with migratory osteoporosis (MO) which initially presented as pain with bone marrow edema (BME) evident in magnetic resonance imaging (MRI) of the left ankle and was managed with non-weight-bearing (NWB). The patient was already treated with per os risedrona...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Musculoskelet Neuronal Interact
Main Authors: Evangelatos, Gerasimos, Fragoulis, George E., Anastasilakis, Athanasios D., Iliopoulos, Alexios
פורמט: Artigo
שפה:Inglês
יצא לאור: International Society of Musculoskeletal and Neuronal Interactions 2021
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC8020026/
https://ncbi.nlm.nih.gov/pubmed/33657764
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!